Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45 USD | +6.38% |
|
+40.80% | +76.75% |
07-15 | Transcript : Kymera Therapeutics, Inc. Presents at UBS Virtual Targeted Protein Degradation Day, Jul-15-2024 01:00 PM | |
07-09 | Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.75% | 2.76B | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- B. Riley Adjusts Price Target on Kymera Therapeutics to $36 From $31, Maintains Neutral Rating